Travere Therapeutics to Present at the BofA Securities 2022 Healthcare Conference
03 mai 2022 16h30 HE
|
Travere Therapeutics, Inc.
SAN DIEGO, May 03, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president and chief executive officer, will present at the BofA...
Retrophin Names Eric Dube, Ph.D. President and Chief Executive Officer
03 janv. 2019 16h30 HE
|
Retrophin, Inc.
Dr. Dube brings proven track record of global leadership built upon significant commercial and operational success Dr. Dube succeeds Stephen Aselage, who will continue serving on Board SAN...